115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TET2 and TP53 mutations cooperate in leukemia development and modulate the response to inflammation
    Meeting Abstract

    Vela, P. S.; Kelly, B.; Brady, C.; Foox, J.; Glass, J.; Levine, R. L.; Shih, A. L.
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment of relapsed/refractory multiple myeloma with ciltacabtagene autoleucel or idecabtagene vicleucel in racial minorities - A multicenter study
    Meeting Abstract

    Chang, D.; Habib, A.; Vegel, A.; Struble, E.; Shaikh, H.; Strouse, C.; Green, K. M.; Mushtaq, M. U.; Mahmoudjafari, Z.; Hashmi, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Interferon inhibits netosis in neutrophils derived from patients with myeloproliferative neoplasms in a neutrophil subpopulation-specific manner
    Meeting Abstract

    Goldberg, I.; Partouche, S.; Halperin, E.; Atamna, B.; Abulafia, A. S.; Shapira, S.; Samara, A.; Gover-Proaktor, A.; Leader, A.; Spectre, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genetic diversity drives differing morphological and clinical presentation and survival in myelodysplastic-type CMML with a low absolute monocyte count
    Meeting Abstract

    Lachowiez, C. A.; Asimomitis, G.; Bernard, E.; Tazi, Y.; Creignou, M.; Germing, U.; Gattermann, N.; Gilkes, A.; Thomas, I.; Bullinger, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial
    Meeting Abstract

    Cortes, J. E.; Rea, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M. W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Representation of older adults in FDA and EMA registrational trials for acute myeloid leukemia (AML)
    Meeting Abstract

    Pugh, K.; Juthani, R.; Torka, P.; Neuendorff, N.
    Blood (2024)

    Fulltext@MSK | Save
  • Reduction in platelet counts may predict the development of immune effector cell associated neurotoxicity syndrome in patients receiving CD19 CAR-T cell therapy for relapsed/refractory large B cell lymphoma
    Meeting Abstract

    Khatib, H.; Parizat, A.; Halloun, J.; Shouval, R.; Shibli, N.; Alalouf, O.; Zuckerman, T.; Vahaba, N.; Halamish, I.; Sapir, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Budde, E. L.; Matasar, M.; Sehn, L. H.; Assouline, S. E.; Kuruvilla, J.; Flinn, I. W.; Yoon, S. S.; Bosch, F.; Greenwald, D.; Gutierrez, N. C.; more...
    Blood (2024)

    Fulltext@MSK | Save